Mutis T, Cornelisse Y E, Datema G, van den Elsen P J, Ottenhoff T H, de Vries R R
Department of Immunohematology, University Hospital Leiden, The Netherlands.
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9456-60. doi: 10.1073/pnas.91.20.9456.
The quality of the response produced by regulatory or helper T (Th) cells presently receives much attention because of its possible implications for vaccine development and immunomodulation. Apart from cytokines and so-called costimulatory signals, antigens and the presenting major histocompatibility complex (MHC) molecules may play a role in determining the type of T-cell response generated toward antigens. To examine the role of antigen and/or HLA in control of T-cell subset activation, we have studied a special case, namely CD4+ suppressor T (Ts) cells in leprosy. Mycobacterium leprae-induced Ts cell clones have been previously isolated from peripheral blood and skin lesions of lepromatous leprosy patients and were shown to specifically down-regulate mycobacterium-specific Th cell responses. Despite considerable effort, the antigens recognized by these Ts cells have thus far not been identified. Here we report that all HLA-DR2-restricted CD4+ Ts cell clones derived from a lepromatous leprosy patient recognize an epitope that maps between the amino acid residues 439 and 448 of the mycobacterial hsp65. The peptide was presented to these Ts cells by HLA-DRB1*1503, a recently discovered HLA-DR2 variant. Non-suppressor T-cell clones derived from the same patient recognized antigens other than the hsp65 and were also stimulated by other HLA-DR2 variants. In independent cloning experiments peptide 435-449 and recombinant hsp65 induced exclusively Ts cells in this lepromatous leprosy patient. The Ts clones recognizing this particular epitope were derived from at least seven different progenitors, as they expressed different T-cell receptor alpha and beta chains. Thus, our data indicate that a specific peptide-HLA class II combination may exclusively activate Ts cells.
调节性T细胞或辅助性T(Th)细胞产生的应答质量目前备受关注,因为其可能对疫苗开发和免疫调节产生影响。除细胞因子和所谓的共刺激信号外,抗原和呈递主要组织相容性复合体(MHC)分子可能在决定针对抗原产生的T细胞应答类型中发挥作用。为了研究抗原和/或HLA在控制T细胞亚群激活中的作用,我们研究了一个特殊情况,即麻风病中的CD4 +抑制性T(Ts)细胞。麻风分枝杆菌诱导的Ts细胞克隆先前已从瘤型麻风病患者的外周血和皮肤病变中分离出来,并显示出可特异性下调分枝杆菌特异性Th细胞应答。尽管付出了巨大努力,但迄今为止这些Ts细胞识别的抗原尚未确定。在此我们报告,来自一名瘤型麻风病患者的所有HLA-DR2限制性CD4 + Ts细胞克隆均识别位于分枝杆菌hsp65氨基酸残基439和448之间的一个表位。该肽由最近发现的HLA-DR2变体HLA-DRB1*1503呈递给这些Ts细胞。来自同一患者的非抑制性T细胞克隆识别hsp65以外的抗原,并且也受到其他HLA-DR2变体的刺激。在独立的克隆实验中,肽435-449和重组hsp65在该瘤型麻风病患者中仅诱导出Ts细胞。识别这一特定表位的Ts克隆源自至少七个不同的祖细胞,因为它们表达不同的T细胞受体α和β链。因此,我们的数据表明特定的肽-HLA II类组合可能专门激活Ts细胞。